1. Home
  2. TXMD vs POAS Comparison

TXMD vs POAS Comparison

Compare TXMD & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.98

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$2.36

Market Cap

22.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
TXMD
POAS
Founded
2008
2017
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
22.9M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
TXMD
POAS
Price
$1.98
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.6K
650.4K
Earning Date
05-12-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
73.68
N/A
EPS
N/A
N/A
Revenue
$1,761,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
35.25
N/A
52 Week Low
$0.98
$0.53
52 Week High
$2.95
$7.40

Technical Indicators

Market Signals
Indicator
TXMD
POAS
Relative Strength Index (RSI) 39.25 61.13
Support Level $1.94 $1.40
Resistance Level $2.05 $3.84
Average True Range (ATR) 0.12 0.18
MACD -0.01 0.03
Stochastic Oscillator 12.50 84.46

Price Performance

Historical Comparison
TXMD
POAS

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

Share on Social Networks: